Oveporexton, a novel first-in-class OX2R-selective agonist, shows promise for improving memory, attention, and executive function in individuals with narcolepsy type 1.

Researchers identified abnormal background brain activity as a measurable marker of ADHD. In a randomized trial, non-invasive ...

Year One: no Cabinet firings. That’s not stability—it’s silence. An “army counsel” is exactly what the West Wing now lacks.

The “gender-affirming” treatment model for minors rests on a pair of Dutch studies. The studies were considered the “gold ...

As Robert F. Kennedy Jr. signals a fat-friendlier approach to dietary guidelines, a new review offers fodder for opposing ...

The Trump administration has awarded a $1.6 million, no-bid contract a Danish university to study hepatitis B vaccinations on ...

Dr. Vinay Prasad: "The establishment, the people who set the policies, they have to strive to get things right. They need to do studies. They need to be held to the highest standard." ...

Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...

Introduction Nasogastric tubes (NGTs) are standard practice in the management of adhesive small bowel obstruction (ASBO). Their insertion can be associated with significant patient discomfort and ...

Whole milk may be on its way back to school lunch trays — but a newly approved bill clears the way for schools to start serving more nondairy beverages like fortified soy milk, too.

A novel way for governments and corporations to shape AI’s impact is to create advance market commitments that create ...